Pre-Session Views

In today's views Strategy | Nile Pharma (NIPH) is closing in on Rameda and this may trigger arbitrage opportunitiesISPH | The decline in ISPH stock price yesterday confirms that 3Q25 results are strong.VALU | 9M25 bottom line is consistent with a full year target of EGP750 million ETEL | Share price is approaching our FV upper end of EGP73/share, what is incorporated and what’s not?MFPC | 3Q soft on volumes and FX, but gas policy shield supports premium EGCH | Resilient margi...